![1]()
News
ICMs detect serious arrhythmias in high-risk post-MI patients: SMART-MI
August 27, 2021
In patients with modestly reduced left ventricular ejection fraction after MI, implantable monitors detect many times more arrhythmias than usual care, the SMART-MI trial showed.
![1]()
News
Optimizing screening for asymptomatic Afib
August 27, 2021
How can we optimize screening for patients with asymptomatic atrial fibrillation (Afib)?
![1]()
News
EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough
August 27, 2021
Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result.
![1]()
News
ACE-I or ARB therapy in patients with low eGFR
August 26, 2021
Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose estimated glomerular filtration rate (eGFR) has decreased to below 30 mL/min per 1.73 m2?
![1]()
News
SGLT2 inhibitor use rising in patients with DKD
August 23, 2021
Use of SGLT2 inhibitors in patients with type 2 diabetes rose sharply in 2019 and early 2020. GLP-1 RA use also showed recent gains.
![1]()
News
Apixaban more effective, safer than rivaroxaban for Afib patients
August 23, 2021
Is apixaban more effective and safer than rivaroxaban in patients with atrial fibrillation?
News
Empagliflozin gets HFrEF approval from FDA
August 19, 2021
The SGLT2 inhibitor empagliflozin (Jardiance) becomes the second agent from this class to get a heart failure indication regardless of diabetes status.
![1]()
News
Use of point-of-care ultrasound (POCUS) for heart failure
August 16, 2021
Hospitalist use of POCUS may include guiding procedures, aiding in diagnosis, and assessing effectiveness of treatment.
![1]()
News
Heparin’s COVID-19 benefit greatest in moderately ill patients
August 13, 2021
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients.
News
Tachycardia syndrome may be distinct marker for long COVID
August 13, 2021
Post-COVID patients with palpitations or chest pain should undergo a cardiac workup, new research suggests. The data also shed light on potential treatments.
